Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

• Status: Completed
• Trial end date: 2014-07-01

Summary

Randomized phase III trial to compare the effectiveness of immediate adjuvant chemotherapy with that of adjuvant chemotherapy given when the cancer returns in treating patients who have undergone a radical cystectomy for stage III or stage IV transitional cell carcinoma of the bladder urothelium. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them after surgery may kill any remaining tumor cells. It is not yet known if adjuvant chemotherapy is more effective when given immediately after radical cystectomy (surgery to remove the bladder) or when the cancer returns.

• Phase: Phase 3

Details

• Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
• Collaborators: Arbeitsgemeinschaft Urologische Onkologie; Groupe D'Etude des Tumeurs Uro-Genitales; Institute of Cancer Research, United Kingdom; National Cancer Institute (NCI); NCIC Clinical Trials Group
• Treatments: Doxorubicin; Gemcitabine; Liposomal doxorubicin; Methotrexate; Vinblastine